| |
| |
|
| Insider
Information: |
Omenn Gilbert S |
| Relationship: |
Director |
| City: |
Ann Arbor |
| State: |
MI |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
259,816 |
|
|
Indirect Shares
|
164,582 |
|
|
| Direct
Value |
$57,806,033 |
|
|
|
Indirect Value
|
$1,892,483 |
|
|
| Total
Shares |
424,398 |
|
|
| Total
Value |
$59,698,516 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amgen Inc |
AMGN |
Director |
2014-04-25 |
180,547 |
2004-12-09 |
5,590 |
Premium* |
|
|
TearLab Corp |
TEAR |
Director |
2005-10-05 |
2,500 |
2005-10-05 |
0 |
Premium* |
|
|
Galectin Therapeutics Inc |
GALT |
Director |
2019-05-31 |
66,769 |
|
0 |
Premium* |
|
|
Esperion Therapeutics, Inc. |
ESPR |
Director |
2017-03-21 |
10,000 |
2017-03-21 |
1,000 |
Premium* |
|
|
Amesite Inc. |
AMST |
Director |
|
0 |
2021-12-14 |
77,666 |
Premium* |
|
|
Elicio Therapeutics Ord Shs |
ELTX |
Director |
|
0 |
2021-02-09 |
80,326 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
64 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMGN |
Amgen Inc |
Director |
• • – |
2013-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,845 |
178,669 |
0 |
- |
|
| AMGN |
Amgen Inc |
officerTitle |
– • – |
2006-01-25 |
4 |
D |
$74.94 |
$141,262 |
D/D |
(1,885) |
175,657 |
|
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2009-04-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,982 |
1,982 |
0 |
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2005-03-07 |
4 |
S |
$62.50 |
$125,055 |
D/D |
(2,000) |
167,011 |
|
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2006-03-01 |
4 |
S |
$76.11 |
$152,373 |
D/D |
(2,000) |
168,657 |
|
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2007-01-25 |
4 |
D |
$75.14 |
$159,297 |
D/D |
(2,120) |
176,192 |
0 |
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2005-01-19 |
4 |
D |
$64.16 |
$141,152 |
D/D |
(2,200) |
176,011 |
|
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2004-01-21 |
4 |
D |
$62.95 |
$138,553 |
D/D |
(2,201) |
159,188 |
|
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2008-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,373 |
192,840 |
0 |
- |
|
| TEAR |
TearLab Corp |
Director |
– • – |
2005-10-05 |
4 |
B |
$6.43 |
$16,063 |
D/D |
2,500 |
2,500 |
2.39 |
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2012-02-29 |
4 |
D |
$68.15 |
$293,113 |
D/D |
(4,301) |
183,852 |
0 |
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2008-01-23 |
4 |
D |
$45.45 |
$196,480 |
D/D |
(4,323) |
189,467 |
0 |
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2012-02-29 |
4 |
OE |
$58.61 |
$293,050 |
D/D |
5,000 |
188,153 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2014-10-21 |
4 |
B |
$20.00 |
$100,000 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2016-03-01 |
4 |
B |
$15.28 |
$76,400 |
D/D |
5,000 |
10,000 |
2.39 |
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2006-02-22 |
4 |
S |
$74.99 |
$450,769 |
D/D |
(6,000) |
169,657 |
|
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2005-02-11 |
4 |
S |
$63.15 |
$443,760 |
D/D |
(7,000) |
169,011 |
|
- |
|
| AMST |
Amesite Inc. |
Director |
– • – |
2021-12-13 |
4 |
B |
$1.18 |
$9,471 |
I/I |
8,000 |
69,666 |
2.1 |
- |
|
| AMST |
Amesite Inc. |
Director |
– • – |
2021-12-14 |
4 |
B |
$1.17 |
$9,354 |
I/I |
8,000 |
77,666 |
2.1 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2018-09-10 |
4 |
S |
$6.00 |
$50,220 |
D/D |
(8,370) |
48,191 |
0 |
- |
|
| AMGN |
Amgen Inc |
Director |
• • – |
2012-10-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
8,572 |
176,783 |
0 |
- |
|
| AMGN |
Amgen Inc |
officerTitle |
– • – |
2006-01-25 |
4 |
OE |
$14.72 |
$141,300 |
D/D |
9,600 |
177,542 |
|
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2018-09-07 |
4 |
S |
$6.03 |
$66,365 |
D/D |
(11,000) |
56,561 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2015-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
11,112 |
40,121 |
0 |
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2007-01-25 |
4 |
A |
$13.73 |
$159,319 |
D/D |
11,600 |
178,312 |
0 |
- |
|
64 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
